Combination of NHF and Nebulizer on Lung Function in COPD
NCT ID: NCT02885103
Last Updated: 2018-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2016-08-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiological and Clinical Changes in NHF Therapy
NCT02504814
Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness
NCT05053074
The Role of HNHF to Improve Clinical Outcomes Following Severe AECOPD
NCT03899558
Nasal High Flow to Maintain the Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients
NCT03882372
Efficacy and Physiology of Nasal High Flow Therapy
NCT02083120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inhalation with nebulizer
inhalation with an nebulizer via mouth
Nebulizer
Inhalation will be done will Nebulizer and via mouth
inhalation with nebulizer and NHF
inhalation with combination of nebulizer and nasal high flow (NHF) via nasal cavity
Nasal high flow (NHF)
NHF will be combinated with a nebulizer. Inhalation will be done on nasal cavity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasal high flow (NHF)
NHF will be combinated with a nebulizer. Inhalation will be done on nasal cavity.
Nebulizer
Inhalation will be done will Nebulizer and via mouth
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD
Exclusion Criteria
* right heart decompensation
* acute respiratory insufficiency
* acute disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Bräunlich, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hubert Wirtz, MD
Role: STUDY_DIRECTOR
University of Leipzig
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Respiratory Medicine
Leipzig, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Braunlich J, Wirtz H. Oral Versus Nasal High-Flow Bronchodilator Inhalation in Chronic Obstructive Pulmonary Disease. J Aerosol Med Pulm Drug Deliv. 2018 Aug;31(4):248-254. doi: 10.1089/jamp.2017.1432. Epub 2017 Dec 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
349-15-24082015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.